TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cytokinetics, Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Bronstein, Gewirtz & Grossman Llc
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cytokinetics, Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

A class action lawsuit has been filed against Cytokinetics for allegedly making false and misleading statements about its New Drug Application timeline and FDA approval process for aficamten, potentially misrepresenting regulatory risks.

Insights
BACpK   negative

Buffett sold 41% of Berkshire's stake due to potential interest rate sensitivity, high valuation premium, and potential future tax considerations


CYTK   negative

The lawsuit alleges the company made materially false statements about its drug application timeline, misrepresented FDA approval expectations, and failed to disclose critical regulatory risks, suggesting potential corporate misconduct